- Home
- MDGL vs BEP Comparison
MDGL vs BEP Comparison
Compare MDGL & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- BEP
- Stock Information
- Founded
- MDGL 2011
- BEP 1999
- Country
- MDGL United States
- BEP Canada
- Employees
- MDGL N/A
- BEP N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- BEP Electric Utilities: Central
- Sector
- MDGL Health Care
- BEP Utilities
- Exchange
- MDGL Nasdaq
- BEP Nasdaq
- Market Cap
- MDGL 6.1B
- BEP 7.3B
- IPO Year
- MDGL N/A
- BEP N/A
- Fundamental
- Price
- MDGL $424.95
- BEP $25.66
- Analyst Decision
- MDGL Strong Buy
- BEP Buy
- Analyst Count
- MDGL 10
- BEP 8
- Target Price
- MDGL $474.67
- BEP $31.25
- AVG Volume (30 Days)
- MDGL 383.6K
- BEP 428.2K
- Earning Date
- MDGL 10-30-2025
- BEP 11-07-2025
- Dividend Yield
- MDGL N/A
- BEP 5.82%
- EPS Growth
- MDGL N/A
- BEP N/A
- EPS
- MDGL N/A
- BEP N/A
- Revenue
- MDGL $515,547,000.00
- BEP $6,174,000,000.00
- Revenue This Year
- MDGL $394.12
- BEP $18.12
- Revenue Next Year
- MDGL $57.74
- BEP $5.94
- P/E Ratio
- MDGL N/A
- BEP N/A
- Revenue Growth
- MDGL 3421.98
- BEP 12.75
- 52 Week Low
- MDGL $200.63
- BEP $19.29
- 52 Week High
- MDGL $457.16
- BEP $29.56
- Technical
- Relative Strength Index (RSI)
- MDGL 58.68
- BEP 55.48
- Support Level
- MDGL $425.00
- BEP $24.91
- Resistance Level
- MDGL $440.90
- BEP $25.50
- Average True Range (ATR)
- MDGL 14.17
- BEP 0.43
- MACD
- MDGL -4.03
- BEP 0.08
- Stochastic Oscillator
- MDGL 28.61
- BEP 79.47
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.